Medicalization of global health 3: The medicalization of the non-communicable diseases agenda

Global Health Action

Volumn 7, Issue SUPP.1, 2014, Pages

  Clark, Jocalyn ^a,b  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chronic disease; Global health; Medicalization; Non communicable disease; Sociology

Indexed keywords

CHRONIC DISEASE; HEALTH; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HUMAN; MANPOWER; MEDICALIZATION; ORGANIZATION; ORGANIZATION AND MANAGEMENT;

CHRONIC DISEASE; DELIVERY OF HEALTH CARE; GLOBAL HEALTH; HEALTH CARE SECTOR; HEALTH PLANNING; HEALTH PRIORITIES; HUMANS; MEDICALIZATION; ORGANIZATIONS;

EID: 84904414513     PISSN: None     EISSN: 16549880     Source Type: Journal    
DOI: 10.3402/gha.v7.24002     Document Type: Article

References (61)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-128.
2. WHO (2013). Noncommunicable diseases. Geneva: World Health Organization.
3. Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The global economic burden of noncommunicable diseases. Geneva: World Economic Forum; 2011.
4. Nugent R, Feigl AB. Where have all the donors gone? Scarce funding for non-communicable disease. Working paper 228. Washington, DC: Center for Global Development; 2010.
5. Alleyne A, Binagwaho A, Haines A, Jahan S, Nugent R, Rojhani A, et al. Embedding non-communicable diseases in the post-2015 development agenda. Lancet 2013; 381: 566-74.
6. Chan M. The worldwide rise of chronic noncommunicable diseases: a slow-motion catastrophe. Opening remarks at the First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control, Moscow, Russian Federation, 28 April 2011.
7. NCD Alliance. NCD Facts. Available from: http://www.ncdalliance.org/ncd-fact [cited 4 January 2014].
8. United Nations (2011). Political declaration of the high-level meeting of the general assembly on the prevention and control of noncommunicable diseases. New York: UN.
9. NCD Alliance. Putting non-communicable diseases on the global agenda. Available from: http://www.ncdalliance.org/[cited 4 January 2014].
10. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-communicable disease crisis. Lancet 2011; 377: 1438-47.
11. Smith R. A global research network for non-communicable diseases. Lancet 2013. Available from: http://dx.doi.org/10.1016/S0140-6736(13)61808-5 [cited 4 January 2014].
12. WHO (2013). Global action plan for the for the prevention and control of noncommunicable diseases (NCDs) 2013-2020. Geneva: World Health Organization.
13. WHO, UNICEF, Government of Sweden, Government of Botswana. Health in the post-2015 agenda. Report of the global thematic consultation on health. Available from: http://www. worldwewant2015.org/file/337378/download/366802 [cited 4 January 2014].
14. Canfin P, Eide EB, Natalegawa M, Ndiaye M, Nkoana-Mashabane M, Patriota A, et al. Our common vision for the positioning and role of health to advance the UN development agenda beyond 2015. Lancet 2013; 381: 1885-6.
15. High-Level Panel of Eminent Persons, A new global partnership: eradicate poverty and transform economies through sustainable development. The Report of the High-Level Panel of Eminent Persons on the Post-2015 Development Agenda. Available from: http://www.post2015hlp.org/wp-content/uploads/2013/05/UN-Report.pdf [cited 4 January 2014].
16. Bonita R, Magnusson R, Bovet P, Zhao D, Malta DC, Geneau R, et al. Country actions to meet UN commitments on noncommunicable diseases: a stepwise approach. Lancet 2013; 381: 575-84.
17. Clark J. Medicalization of global health 1: has the global health agenda become too medicalized? Glob Health Action 2014; 7: 23998.
18. Clark J. Medicalization of global health 2: the medicalization of global mental health. Glob Health Action 2014; 7: 24000.
19. WHO (2011). Scaling up action against non-communicable diseases. Geneva: World Health Organization.
20. Smith R. Global response to non-communicable disease. BMJ 2011; 342: d3823.
21. Conrad P. The shifting engines of medicalization. J Health Soc Behav 2005; 46: 3-14.
22. Blackburn G. Medicalizing obesity: individual, economic, and medical consequences. Am Med Assoc J Ethics 2011; 13: 890-5.
23. Baum FE, Sanders DM. Ottawa 25 years on: a more radical agenda for health equity is still required. Health Promot Int 2011; 26(Suppl 2): 253-7.
24. Hunter D, Popay J, Tannahill C, Whitehead M. Getting to grips with health inequalities at last? BMJ 2010; 340: c684.
25. Moodie R, Stuckler D, Monteiro, Sheron N, Neal B, Thamarangsi T, et al. Profits and pandemics: prevention of harmful effects tobacco, alcohol, and ultra-processed food and drink industries. Lancet 2013; 381: 670-9.
26. Hunter DJ, Reddy KS. Global health: noncommunicable diseases. N Engl J Med 2013; 369: 1336-43.
27. Stuckler D, Siegel K, O'Connor Duffany K, Kishore S, Stevens D, Basu S. Comprehensive strategies to reduce the burden of chronic diseases. In Stuckler D, Siegel K, eds. Sick societies: responding to the global challenge of chronic Disease. Oxford: Oxford University Press; 2011, pp. 87-134.
28. Sadler JZ, Jotterand F, Lee SC, Inrigh S. Can medicalization be good? Situating medicalization within bioethics. Theor Med Bioeth 2009; 30: 411-25.
29. Veerman L. September 21, 2011. Stemming the obesity epidemic requires courageous, population-level action. Available from: http://theconversation.com/stemming-the-obesity-epidemic-requires-courageous-population-level-action-3412 [cited 4 January 2014].
30. Stuckler D, Basu S, McKee M. Commentary: UN high level meeting on non-communicable diseases: an opportunity for whom? BMJ 2011; 343: d5336. DOI: 10.1136/bmj.d5336.
31. Whipfli H. September 9, 2013. Partnerships of peril: Keeping food, alcohol and beverage industries out of global health governance. Available from: http://blogs.plos.org/speakingof medicine/2013/09/25/partnerships-of-peril-keeping-food-alcoholand-beverage-industries-out-of-global-health-governance/[cited 4 January 2014].
32. WHO (2009). WHO Report on the global tobacco epidemic, 2009. The MPOWER package. Geneva: World Health Organization.
33. Friel S, Labonte R, Sanders D. Measuring progress on dietrelated NCDs: the need to address the causes of the causes. Lancet 2013; 381: 903.
34. Swinburn B, Sacks G, Vandevijvere S, Kumanyika S, Lobstein T, Neal B, et al. INFORMAS (International Network for Food and Obesity/non-communicable diseases Research, Monitoring and Action Support): Overview and key principles. Obes Rev 2013; 14(Suppl 1): 1-12.
35. Sanders D. The medicalization of health care and the challenge of health for all. Background paper for People's Health Assembly I. 2000. Available from: http://phm.phmovement.org/pipermail/phm-exchange-phmovement.org/attachments/20010826/c8862696/attachment.pdf [cited 4 January 2014].
36. Stuckler D, Basu S, King L, Steele S, McKee M. Politics of chronic disease. In Stuckler D, Siegel K, eds. Sick societies: responding to the global challenge of chronic Disease. Oxford: Oxford University Press; 2011, pp. 135-184.
37. International Diabetes Federation, Union for International Cancer Control and the World Heart Federation (2009). Time to act: The global emergency of non-communicable diseases. Available from: http://ncdalliance.org/sites/default/files/resource-files/timetoact.pdf [cited 4 January 2014].
38. Hogerzeil HV, Liberman J, Wirtz V, Kishore SP, Selvaraj S, Kiddell-Monroe R, et al. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet 2013; 381: 680-9.
39. Rooke C. Harm reduction and the medicalization of tobacco use. Sociol Health & Illness 2012; 35: 361-76.
40. Smith R. UN meeting on NCDs - day two. September 21, 2011. Available from: http://blogs.bmj.com/bmj/2011/09/21/richardsmith-un-meeting-on-ncds-day-two/[cited 4 January 2014].
41. Patton C. Inventing AIDS. London: Routledge; 1991.
42. Our Bodies, Ourselves. Boston Women's Collective. New York: Touchstone Book/Simon & Schuster; 2011.
43. International Diabetes Federation, International Union Against Tuberculosis and Lung Disease, Union for International Cancer Control and the World Heart Federation. Proposed outcomes document for the United Nations high-level summit on noncommunicable diseases. Available from: www.ncdalliance.org/sites/default/files/rfiles/NCDAlliance Proposed Outcomes Document for the UN High-Level Summit-0.pdf [cited 4 January 2014].
44. NCD Alliance Statement on Political Declaration. World leaders make strong commitment to addressing the global noncommunicable disease crisis. Available from: http://ncdalliance. org/sites/default/files/resource-files/NCD-Alliance-statement-on-Political-Declaration-11-Sept.pdf [cited 4 January 2014].
45. Heath I. Seeming virtuous on chronic diseases. BMJ 2011; 343: d4239.
46. Moynihan R. Who benefits from treating pre-hypertension? BMJ 2010; 341: c4442.
47. Ioannidis J. More than a billion people taking statins? Potential implications of the new cardiovascular guidelines. JAMA 2014; 311: 463-4. DOI: 10.1001/jama.2013.284657.
48. PriceWaterhouseCoopers LLC (2012). From vision to decision: Pharma 2020. Available from: http://download.pwc.com/ie/pubs/2012-pharma-2020.pdf [cited 4 January 2014].
49. IMS Institute for Healthcare Informatics (2012). The global use of medicines: outlook through 2016. Parsippany, NJ: IMS Institute for Healthcare Informatics.
50. Bollyky TJ. Access to drugs for treatment of noncommunicable diseases. PLoS Med 2013; 10: e1001485. DOI: 10.1371/journal. pmed.1001485.
51. Steffens M. Therapeutic vaccines: a new hope for chronic disease? SciDevNet 2008. Available from: http://www.scidev.net/global/health/feature/therapeutic-vaccines-a-new-hope-forchronic-diseas.html [cited 4 January 2014].
52. Heath I. Overdiagnosis: when good intentions meet vested interests-an essay. BMJ 2013; 347: f6361.
53. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ 2012; 344: e3502. DOI: 10.1136/bmj.e3502.
54. Jamison DT, Summers LH, Alleyne G, Arrow KJ, Berkley S, Binagwaho A, et al. Global health 2035: a world converging within a generation. Lancet 2013; 382: 1898-955.
55. Victora CG, WagstaffA, Schellenberg JA, Gwatkin D, Claeson M, Habicht JP. Applying an equity lens to child health and mortality: more of the same is not enough. Lancet 2003; 362: 233-41.
56. McCoy D, Sanders D, Baum F, Narayan T, Legge D. Pushing the international health research agenda towards equity and effectiveness. Lancet 2004; 364: 1630-1.
57. Navarro V. What do we mean by social determinants of health? Glob Health Promot 2009; 16: 5-16.
58. Navarro V. Politics and health: a neglected area of research. Eur J Public Health 2008; 18: 354-6.
59. D'Ambruoso L. Global health post-2015: the case for universal health equity. Glob Health Action 2013; 6: 19661.
60. Hancock C, Kingo L, Raynaud O. The private sector, international development and NCDs. Global Health 2011; 7: 23.
61. Smith R. The polypill is about demedicalisation not medicalisation. Available from: http://blogs.bmj.com/bmj/2009/05/01/richard-smith-the-polypill-is-about-demedicalisation-not-medicalisation/[cited 4 January 2014].